NuGen Medical Devices Inc (NGMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NuGen Medical Devices Inc (NGMD) has a cash flow conversion efficiency ratio of 0.072x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-982.19K ≈ $-710.50K USD) by net assets (CA$-13.74 Million ≈ $-9.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NGMD equity to assets ratio to measure how much of total assets are equity-financed.
NuGen Medical Devices Inc - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how NuGen Medical Devices Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check NuGen Medical Devices Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
NuGen Medical Devices Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NuGen Medical Devices Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Celtic PLC
LSE:CCP
|
-0.038x |
|
CL8 Holdings Ltd
AU:CL8
|
0.158x |
|
John Wood Group PLC
LSE:WG
|
-0.763x |
|
Scout Security Ltd
AU:SCT
|
-0.203x |
|
Lanesborough Real Estate Investment Trust
V:LRT-UN
|
0.011x |
|
ROUTE1 INC.
F:3R6N
|
-0.683x |
|
Baronsmead Second Venture Trust Plc
LSE:BMD
|
-0.008x |
|
Creative Medical Technology Holdings Inc
NASDAQ:CELZ
|
-0.216x |
Annual Cash Flow Conversion Efficiency for NuGen Medical Devices Inc (2020–2025)
The table below shows the annual cash flow conversion efficiency of NuGen Medical Devices Inc from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see NGMD market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$-13.74 Million ≈ $-9.94 Million |
CA$-3.57 Million ≈ $-2.58 Million |
0.260x | -68.76% |
| 2024-12-31 | CA$-5.67 Million ≈ $-4.10 Million |
CA$-4.71 Million ≈ $-3.41 Million |
0.831x | -74.50% |
| 2023-12-31 | CA$-2.06 Million ≈ $-1.49 Million |
CA$-6.71 Million ≈ $-4.86 Million |
3.259x | +51.03% |
| 2022-12-31 | CA$-2.26 Million ≈ $-1.64 Million |
CA$-4.88 Million ≈ $-3.53 Million |
2.158x | +187.35% |
| 2021-12-31 | CA$1.66 Million ≈ $1.20 Million |
CA$-4.10 Million ≈ $-2.96 Million |
-2.470x | -222.69% |
| 2020-12-31 | CA$-692.25K ≈ $-500.76K |
CA$-1.39 Million ≈ $-1.01 Million |
2.013x | -- |
About NuGen Medical Devices Inc
NuGen Medical Devices Inc., a specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, vaccines, veterinary, home healthcare, and others. It also provides Ins… Read more